Trulieve Cannabis TRLV
NYSE TRLV
$9.65 +0.18 (+1.90%)
At close: Aug 18, 2026 · 3:59 PM UTC

Trulieve Cannabis (TRLV) EBT (2020 - 2026)

Trulieve Cannabis (TRLV) posted quarterly EBT of $25.2 million for Q1 2026, up 24.07% year-over-year from $20.3 million in Q1 2025, and up 757.53% quarter-over-quarter from $2.9 million in Q4 2025.

Trulieve Cannabis (TRLV) EBT (2020 - 2026) Analysis & Trends

Trulieve Cannabis' EBT history runs 7 years deep, the most recent figure standing at $25.2 million for Q1 2026.

  • In Q1 2026, EBT rose 24.07% year-over-year to $25.2 million; the TTM figure through Mar 2026 stood at $96.4 million (up 209.91% YoY), while the FY2025 annual figure was $91.5 million, up 114.15% from the prior year.
  • EBT for Q1 2026 stood at $25.2 million, up from $2.9 million in the prior quarter.
  • The five-year high for EBT was $38.9 million in Q2 2025, with the low at -$308.2 million in Q2 2023.
  • The 5-year median for EBT is $13.0 million (2022), against an average of -$8.7 million.
  • The sharpest annual moves came in 2023 and 2024: EBT slumped 1265.17% in 2023, then jumped 2644.5% in 2024.
  • Trulieve Cannabis' EBT stood at -$17.6 million in 2022, then surged by 150.09% to $8.8 million in 2023, then sank by 246.25% to -$12.9 million in 2024, then jumped by 122.79% to $2.9 million in 2025, then jumped by 757.53% to $25.2 million in 2026.
  • Business Quant data shows TRLV's EBT at $25.2 million in Q1 2026, $2.9 million in Q4 2025, and $29.3 million in Q3 2025.

Peer Comparison

Historic Data

Download Data
DateValue
Jun 30, 2026 -383.40 Mn
Mar 31, 2026 25.22 Mn
Dec 31, 2025 2.94 Mn
Sep 30, 2025 29.30 Mn
Jun 30, 2025 38.90 Mn
Mar 31, 2025 20.33 Mn
Dec 31, 2024 -12.90 Mn
Sep 30, 2024 -12.84 Mn
Jun 30, 2024 36.51 Mn
Mar 31, 2024 31.95 Mn
Dec 31, 2023 8.82 Mn
Sep 30, 2023 13.72 Mn
Jun 30, 2023 -308.25 Mn
Mar 31, 2023 1.16 Mn
Dec 31, 2022 -17.61 Mn
Sep 30, 2022 -44.26 Mn
Jun 30, 2022 26.46 Mn
Mar 31, 2022 13.00 Mn
Dec 31, 2021 -18.58 Mn
Sep 30, 2021 60.22 Mn